Safety and PK of BMS-955176 and BMS-955176 with ATV +/- RTV

• Research type

  Research Study

• Full title

  Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Pharmacodynamics, Safety and Pharmacokinetics of BMS-955176 (Double-Blinded) and BMS-955176 with Atazanavir +/- Ritonavir (Open-Labeled) in HIV-1 Infected Subjects Revised protocol 04 (dated 27 Feb 2014), incorporating amendment 05 and administrative letter 02 + Pharmacogenetics Blood Sample Amendment 01 Site Specific(dated 28 Feb 2013).

• IRAS ID

  151254

• Contact name

  Marta Boffito

• Contact email

  marta.boffito@chelwest.nhs.uk

• Sponsor organisation

  Bristol-Myers Squibb International Corporation

• Eudract number

  2012-004124-38

• Clinicaltrials.gov Identifier

  NCT01803074

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  14/LO/0803

• Date of REC Opinion

  11 Jul 2014

• REC opinion

  Further Information Favourable Opinion